XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

1.50
ILA
0.00
(0.00%)
3.61BMarket Cap

Latest Stock Split

Jun 23, 2009

1:5

For every 5 shares held, investors received 1. The price per share adjusted from $11.80 to $59.00.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jun 23, 2009
    Before$11.80
    Split ratio1:5
    After$59.00
    Reverse
  2. Jul 02, 2004
    Before—
    Split ratio38:37
    After—
    Forward

About XTL Biopharmaceuticals Ltd. stock splits

XTL Biopharmaceuticals Ltd. (TASE:XTLB) operates in the Medical specialties industry.

XTL Biopharmaceuticals Ltd. company overview

When did XTL Biopharmaceuticals Ltd. stock split?

XTL Biopharmaceuticals Ltd.'s most recent stock split was on June 23, 2009. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.

What is XTL Biopharmaceuticals Ltd.'s stock split history?

XTL Biopharmaceuticals Ltd. (TASE:XTLB) has split its stock 2 times: a 38-for-37 split on July 2, 2004 and a 1-for-5 reverse split on June 23, 2009.

How many times has XTL Biopharmaceuticals Ltd. stock split?

XTL Biopharmaceuticals Ltd. has split its stock 2 times. This history records 2 splits between July 2, 2004 and June 23, 2009.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In XTL Biopharmaceuticals Ltd.'s 1-for-5 reverse split on June 23, 2009, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will XTL Biopharmaceuticals Ltd. split its stock again?

XTL Biopharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on June 23, 2009, 17 years ago. Companies announce splits in advance, and any new TASE:XTLB split will appear on this page.